How Volatility Is Impacting the Biotech IPO Market

The video discusses the decline in biotech stock prices, with the NASDAQ Biotech index falling 26% due to the sell-off of riskier assets. This has affected the IPO market, making it difficult for biotech companies to raise cash. The number of biotech IPOs has decreased significantly compared to the previous year, highlighting the volatility in the market.

What percentage has the NASDAQ Biotech index fallen over the past year?

• 42%

• 35%

• 26%

• 15%

What has been a major reason for the decline in biotech stock prices?

• Increase in government regulations

• Rise in interest rates

• Sell-off of riskier assets

• Decrease in consumer demand

How has the IPO market for biotech companies been affected by the stock price decline?

• It has remained stable

• It has become icy

• It has become more active

• It has seen a slight increase

How many biotech IPOs have occurred in the current year to date?

• 17

• 12

• 8

• 5

What is a significant trend observed in the biotech market this year?

• Increased investment in biotech startups

• Biotech companies easily raising cash

• Struggle in raising cash

• Stable market conditions